Title : Tumor-Cell-Specific Targeting of Ibrutinib: Introducing Electrostatic Antibody-Inhibitor Conjugates (AiCs).

Pub. Date : 2022 Jan 3

PMID : 34725904






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Ibrutinib is a first-in-class covalent inhibitor of the Bruton s tyrosine kinase inhibitor that has been approved for the treatment of patients with chronic lymphocytic leukemia, mantle cell lymphoma and Waldenstrom"s macroglobulinemia and is connected with toxicities, caused by high dosage. ibrutinib Bruton tyrosine kinase Homo sapiens